Sennosides, USP 1.76 MG/ML Oral Solution — RxCUI 702311
RxNorm drug concept · Semantic clinical drug
RxCUI 702311
Semantic clinical drug · SCD
● Current RxNorm concept 30 FDA products
36 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI702311
Official nameSennosides, USP 1.76 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assennosides 8.8 MG per 5 mL Oral Syrup; sennosides 8.8 MG in 5 mL Oral Solution; sennosides, USP 26.4 MG per 15 ML Oral Solution; sennosides, USP 8.8 MG per 5 ML Oral Solution
FDA products mapped30
Package NDCs mapped36
Reported Medicaid activity (SDUD)117,188 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Senna: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Senna typically produces a bowel movement within 6 to 12 hours. That's why most people take it at bedtime — so it can do its job overnight and you get results in the morning. If no...
- How long does it take for senna to work?
- Senna is designed for short-term, occasional use. You should not use it for more than 1 week unless your doctor specifically tells you it's okay. Using laxatives too often or for t...
- Laxatives like senna can affect how your body absorbs other medications. To be safe, take senna at least 2 hours before or after any other drugs you use. It's always a good idea to...
🕸️ Concept Web — How Sennosides, USP 1.76 MG/ML Oral Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sennosides, USP 1.76 MG/ML Oral Solution
RxCUI 702311 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Sennosides, USP
36387IN
-
Sennosides, USP
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Senexon
219859BN
-
Senexon
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sennosides, USP Oral Solution
376533SCDF -
Sennosides, USP Oral Liquid Product
1159067SCDG -
Sennosides, USP Oral Product
1159068SCDG -
Sennosides, USP Oral Solution [Senexon]
756783SBDF -
Senexon Oral Liquid Product
1178375SBDG -
Senexon Oral Product
1178376SBDG -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Sennosides, USP Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sennosides, USP 1.76 MG/ML
333724SCDC -
Sennosides, USP 1.76 MG/ML Oral Solution [Senexon]
755277SBD -
Sennosides, USP 1.76 MG/ML [Senexon]
604082SBDC
-
Sennosides, USP 1.76 MG/ML
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sennosides, USP 1.76 MG/ML
SCDC · 333724 -
Sennosides, USP Oral Solution
SCDF · 376533 -
Sennosides, USP Oral Liquid Product
SCDG · 1159067 -
Sennosides, USP Oral Product
SCDG · 1159068
Brand-Name Concepts
-
Sennosides, USP 1.76 MG/ML Oral Solution [Senexon]
SBD · 755277 -
Sennosides, USP 1.76 MG/ML [Senexon]
SBDC · 604082 -
Sennosides, USP Oral Solution [Senexon]
SBDF · 756783 -
Senexon Oral Liquid Product
SBDG · 1178375 -
Senexon Oral Product
SBDG · 1178376 -
Senexon
BN · 219859
📦 FDA Products & Package NDCs
30 products · 36 package NDCs
36 package NDCs map to RxCUI 702311 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00121-4967-40 | 4 TRAY in 1 CASE (0121-4967-40) / 10 CUP, UNIT-DOSE in 1 TR... | Senna | PAI Holdings, LLC dba PAI Pharma | 2022-03-22 |
| 00536-1266-59 | 237 mL in 1 BOTTLE (0536-1266-59) | Senna Liquid | RUGBY LABORATORIES | 2019-05-01 |
| 00536-1483-59 | 237 mL in 1 BOTTLE (0536-1483-59) | Senna | Rugby Laboratories | 2026-04-17 |
| 00904-7528-94 | 4 TRAY in 1 CASE (0904-7528-94) / 10 CUP, UNIT-DOSE in 1 TR... | Senna | Major Pharmaceuticals | 2025-03-06 |
| 17856-1127-01 | 120 SYRINGE in 1 BOX, UNIT-DOSE (17856-1127-1) / 2.5 mL in... | OneLAX SENNA | ATLANTIC BIOLOGICALS CORP. | 2024-03-05 |
| 17856-1127-02 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-1127-2) / 5 mL... | OneLAX SENNA | ATLANTIC BIOLOGICALS CORP. | 2024-03-05 |
| 17856-1127-03 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-1127-3) / 10 m... | OneLAX SENNA | ATLANTIC BIOLOGICALS CORP. | 2024-03-05 |
| 17856-1127-04 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-1127-4) / 15 m... | OneLAX SENNA | ATLANTIC BIOLOGICALS CORP. | 2024-03-05 |
| 17856-1127-09 | 120 SYRINGE in 1 BOX, UNIT-DOSE (17856-1127-9) / 2.5 mL in... | OneLAX SENNA | ATLANTIC BIOLOGICALS CORP. | 2025-12-29 |
| 17856-8127-02 | 50 CUP, UNIT-DOSE in 1 CASE (17856-8127-2) / 5 mL in 1 CUP,... | OneLAX SENNA | Atlantic Biologicals Corp. | 2025-10-10 |
| 39328-0020-08 | 237 mL in 1 BOTTLE, PLASTIC (39328-020-08) | Senna | Patrin Pharma, Inc. | 2023-10-01 |
| 39328-0120-50 | 5 TRAY in 1 CASE (39328-120-50) / 10 CUP, UNIT-DOSE in 1 TR... | Senna UD | Patrin Pharma, Inc. | 2023-10-01 |
| 39328-0120-99 | 10 TRAY in 1 CASE (39328-120-99) / 10 CUP, UNIT-DOSE in 1 T... | Senna UD | Patrin Pharma, Inc. | 2024-06-03 |
| 39328-0220-50 | 5 TRAY in 1 CASE (39328-220-50) / 10 CUP, UNIT-DOSE in 1 TR... | Senna UD | Patrin Pharma, Inc. | 2023-10-01 |
| 48433-0219-40 | 40 CUP, UNIT-DOSE in 1 BOX (48433-219-40) / 5 mL in 1 CUP,... | Senna Syrup | Safecor Health, LLC | 2020-03-01 |
| 50268-0731-24 | 24 CUP, UNIT-DOSE in 1 BOX (50268-731-24) / 5 mL in 1 CUP,... | Senna Syrup | AVPAK | 2021-05-03 |
| 54859-0808-08 | 237 mL in 1 BOTTLE (54859-808-08) | Senna Syrup | Llorens Pharmaceutical International Division, Inc. | 2019-05-01 |
| 57237-0301-24 | 237 mL in 1 BOTTLE (57237-301-24) | Senna Syrup | Rising Pharma Holdings, Inc. | 2022-09-27 |
| 57237-0310-54 | 40 CUP, UNIT-DOSE in 1 BOX (57237-310-54) / 5 mL in 1 CUP,... | Senna Syrup | Rising Pharma Holdings, Inc. | 2023-05-23 |
| 57896-0472-08 | 237 mL in 1 BOTTLE (57896-472-08) | GeriCare Senna Syrup | Geri-Care Pharmaceutical Corp. | 2022-04-13 |
| 58657-0518-08 | 237 mL in 1 BOTTLE (58657-518-08) | Senna Syrup | Method Pharmaceuticals | 2021-09-28 |
| 60687-0851-77 | 4 TRAY in 1 CASE (60687-851-77) / 10 CUP, UNIT-DOSE in 1 TR... | Senna | American Health Packaging | 2025-01-02 |
| 63629-9268-01 | 237 mL in 1 BOTTLE (63629-9268-1) | Senna Syrup | Bryant Ranch Prepack | 2024-04-04 |
| 66424-0562-08 | 236 mL in 1 BOTTLE, PLASTIC (66424-562-08) | SENNA Syrup | SDA Laboratories, Inc. | 2015-01-01 |
| 68094-0049-62 | 3 TRAY in 1 CASE (68094-049-62) / 10 CUP, UNIT-DOSE in 1 TR... | SENNA | Precision Dose, Inc. | 2024-06-15 |
| 69618-0069-58 | 237 mL in 1 BOTTLE, PLASTIC (69618-069-58) | SENNA | Reliable 1 Laboratories LLC | 2021-08-03 |
| 71399-0027-08 | 237 mL in 1 BOTTLE (71399-0027-8) | OneLAX SENNA | Akron Pharma Inc. | 2024-02-06 |
| 72090-0022-01 | 237 mL in 1 BOTTLE (72090-022-01) | Senna Syrup | Pioneer Life Sciences, LLC | 2024-10-18 |
| 72162-1672-02 | 237 mL in 1 BOTTLE (72162-1672-2) | Senna Syrup | Bryant Ranch Prepack | 2026-03-25 |
| 73564-0812-08 | 1 BOTTLE in 1 BOX (73564-812-08) / 237 mL in 1 BOTTLE | Senna Syrup | Aldama Pharmaceuticals, Inc | 2026-06-01 |
| 81033-0120-50 | 50 CUP, UNIT-DOSE in 1 CARTON (81033-120-50) / 5 mL in 1 CU... | Senna Syrup | Kesin Pharma Corporation | 2025-05-26 |
| 81033-0120-54 | 50 CUP, UNIT-DOSE in 1 CARTON (81033-120-54) / 10 mL in 1 C... | Senna Syrup | Kesin Pharma Corporation | 2025-10-20 |
| 81033-0120-55 | 50 CUP, UNIT-DOSE in 1 CARTON (81033-120-55) / 15 mL in 1 C... | Senna Syrup | Kesin Pharma Corporation | 2025-10-20 |
| 82568-0024-08 | 237 mL in 1 BOTTLE (82568-0024-8) | Senna | AARNA USA INC. | 2025-02-18 |
| 84415-0021-01 | 100 CUP, UNIT-DOSE in 1 BOX (84415-021-01) / 5 mL in 1 CUP,... | Senna Syrup | Everpharm LLC | 2025-01-16 |
| 84447-0120-01 | 200000 mL in 1 DRUM (84447-120-01) | Senna Liquid | Belleview Biosciences | 2025-05-01 |
Observed labelers:
ATLANTIC BIOLOGICALS CORP. (6) ·
Patrin Pharma, Inc. (4) ·
Kesin Pharma Corporation (3) ·
Bryant Ranch Prepack (2) ·
Rising Pharma Holdings, Inc. (2) ·
Rugby Laboratories (2)
· +17 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.